Catalyst Event
Gilead Sciences Inc (GILD) · Other
From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)
6/2/2026, 12:00:00 AM
Announcement of statistically significant composite ALP normalization for Livdelzi (seladelpar) in the Phase 3 IDEAL trial for Primary Biliary Cholangitis (PBC) on June 2, 2026. Low impact estimated as the market had partially priced in success; expected.
Korean Translation
2026년 6월 2일, 원발성 담즙성 담관염(PBC)에 대한 3상 IDEAL 임상시험에서 리브델지(셀라델파)의 통계적으로 유의미한 복합 ALP 정상화 달성 발표가 예상됨. 시장의 선반영에 따른 낮은 영향이 예상됨.
Related Recent Events
Kinder Morgan Inc. (KMI) · Other
James Holland, Chief Operating Officer, is set to retire, effective September 4, 2026. Ken Grubb, currently VP and Chief Project Officer, will succeed him as COO. The transition was announced on April 22, 2026. Impact is estimated at 1% due to the planned nature of the succession scheduled.
9/4/2026, 12:00:00 AM
HEICO Corp (HEI) · Earnings Release
Q3 2026 earnings release on 2026-08-24 scheduled.
8/24/2026, 12:00:00 AM
Walmart Inc (WMT) · Earnings Release
Q2 FY2027 earnings release scheduled; medium impact from financial updates expected.
8/20/2026, 12:00:00 AM
Target Corp (TGT) · Earnings Release
Q2 2026 earnings release on August 19, 2026, with analysts forecasting an EPS of approximately $2.21-$2.25; low impact estimated as the market typically prices in consensus expectations prior to the release expected.
8/19/2026, 12:00:00 AM
CoreWeave Inc (CRWV) · Earnings Release
Q2 2026 earnings release for August 18, 2026, is of high importance as such releases often cause >10% price impact; event scheduled.
8/18/2026, 12:00:00 AM
Home Depot Inc. (The) (HD) · Earnings Release
Q2 2026 earnings release and conference call on August 18, 2026. Estimated price impact ~5% as earnings releases typically drive significant volatility; scheduled.
8/18/2026, 12:00:00 AM